You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
秘鲁恢复中国国药集团疫苗临床试验
阿思达克 12-17 15:32
秘鲁卫生部长表示,恢复中国国药集团研发的新型冠状病毒疫苗在当地进行临床试验。卫生部长马塞蒂当地周三指,已经与国药集团举行几次会议,决定恢复疫苗试验。《华尔街日报》引述秘鲁一名卫生部官员表示,医生委员会发现该名志愿人士出现的反应与疫苗无关。

秘鲁卫生部日前表示,一名参与试验的志愿人士出现腿部力量下降等症状,决定暂停有关疫苗测试。

国药集团正在秘鲁对大约1.2万名志愿人士进行疫苗临床试验,首阶段试验预期於未来几天完成。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account